ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CALT Calliditas Therapeutics AB

20.64
0.51 (2.53%)
Última actualización: 12:15:26
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Calliditas Therapeutics AB CALT NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.51 2.53% 20.64 12:15:26
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
20.13 20.13 20.64 20.13
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/5/202401:16PRNUSCalliditas announces positive topline results of Phase 2..
06/5/202401:11PRNUSCalliditas announces positive topline results of Phase 2..
24/4/202412:35PRNUSCalliditas Therapeutics' 2023 Annual Report Published
24/4/202412:26PRNUSCalliditas Therapeutics' 2023 Annual Report Published
24/4/202402:30PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
24/4/202402:26PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
18/4/202406:13PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
18/4/202406:10PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
09/4/202406:24PRNUSCalliditas Therapeutics to Attend Conferences in April
09/4/202406:22PRNUSCalliditas Therapeutics to Attend Conferences in April
08/4/202407:38PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
08/4/202407:32PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
08/4/202402:24PRNUSCalliditas receives notice of allowance for United States..
08/4/202402:22PRNUSCalliditas receives notice of allowance for United States..
11/3/202420:28PRNUSEverest Medicines' Partner Calliditas Therapeutics Announces..
06/3/202401:38PRNUSCalliditas announces an additional seven year orphan drug..
06/3/202401:34PRNUSCalliditas announces an additional seven year orphan drug..
01/3/202406:43PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
01/3/202406:39PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
21/2/202400:45PRNUSCalliditas Year-end report, January - December 2023
21/2/202400:43PRNUSCalliditas Year-end report, January - December 2023
14/2/202400:11PRNUSInvitation to the presentation of Calliditas´ Year-end..
14/2/202400:09PRNUSInvitation to the presentation of Calliditas´ Year-end..
13/2/202410:28PRNUSCalliditas provides patent update
13/2/202410:26PRNUSCalliditas provides patent update
08/1/202407:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202401:33PRNUSCalliditas Therapeutics provides business update ahead of JP..
08/1/202401:31PRNUSCalliditas Therapeutics provides business update ahead of JP..
07/1/202410:21PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
07/1/202410:19PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
07/1/202410:07PRNUSCalliditas to present at JP Morgan Healthcare Conference
07/1/202410:05PRNUSCalliditas to present at JP Morgan Healthcare Conference
27/12/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202311:22PRNUSCalliditas refinances existing term loan with Euro 92..
27/12/202311:16PRNUSCalliditas refinances existing term loan with Euro 92..
20/12/202318:00DJNStocks to Watch: Micron, Warner Bros. Discovery, Paramount..
20/12/202316:33DJNCalliditas Therapeutics Shares Rise 33% After FDA Approves..
20/12/202316:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202315:34PRNUSCalliditas Therapeutics announces full FDA approval of..
20/12/202315:33PRNUSCalliditas Therapeutics announces full FDA approval of..
11/12/202308:40PRNUSCalliditas Receives Notice of Allowance for United States..
11/12/202308:38PRNUSCalliditas Receives Notice of Allowance for United States..
01/12/202302:27PRNUSCalliditas announces additions to the management team
01/12/202302:21PRNUSCalliditas announces additions to the management team
30/11/202301:55PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
30/11/202301:49PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
24/11/202302:13PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
24/11/202302:10PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
07/11/202309:31PRNUSCalliditas to present at upcoming investor conferences
07/11/202309:29PRNUSCalliditas to present at upcoming investor conferences

Su Consulta Reciente

Delayed Upgrade Clock